|
US2006084660A1
|
|
Calcium channel blockers comprising two benzhydril moieties
|
|
WO2005097779A1
|
|
Diarylamine derivatives as calcium channel blockers
|
|
US2005227999A1
|
|
Diarylamine derivatives as calcium channel blockers
|
|
BRPI0410871A
|
|
3-Aminomethyl pyrrolidines as n-type calcium channel blockers
|
|
CA2521330A1
|
|
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
US2004044004A1
|
|
Calcium channel inhibitors comprising benzhydril spaced from piperazine
|
|
US2004034035A1
|
|
Calcium channel blockers comprising two benzhydril moieties
|
|
IL150117A
|
|
Substituted piperazine and piperidine calcium channel blockers
|
|
US6492375B2
|
|
Partially saturated calcium channel blockers
|
|
CA2397681A1
|
|
Partially saturated calcium channel blockers
|
|
AU5957100A
|
|
Novel mammalian calcium channels and related probes, cell lines and methods
|
|
US6387897B1
|
|
Preferentially substituted calcium channel blockers
|
|
US6310059B1
|
|
Fused ring calcium channel blockers
|
|
US6267945B1
|
|
Farnesol-related calcium channel blockers
|
|
US6011035A
|
|
Calcium channel blockers
|
|
EP0973889A1
|
|
HUMAN CALCIUM CHANNELS ALFA1i SUBUNITS AND RELATED PROBES, CELL LINES AND METHODS
|
|
US5502037A
|
|
Pro-cytotoxic drug conjugates for anticancer therapy
|
